Publications by authors named "Ruben Gandia-Beneto"

Introduction: The difficulties that patients with attention deficit hyperactivity disorder (ADHD) have when it comes to emotional regulation have aroused a great deal of interest in recent years and there is a line of research working on the identification of the neurophysiological correlates.

Aims: To analyse measures of emotional functioning and their correlation with the P300 component in a sample of children with ADHD with and without treatment.

Patients And Methods: The sample was made up of 71 children with ADHD, almost half of whom were taking some form of medication.

View Article and Find Full Text PDF

Introduction: Attention deficit hyperactivity disorder (ADHD) is a disorder of a biological origin affecting the neurodevelopment of the brain. It is estimated that 3-7% of school-age children present ADHD. The most commonly used pharmacological treatments are amphetamines and methylphenidate (MPH).

View Article and Find Full Text PDF

Introduction: The prevalence of attention deficit hyperactivity disorder (ADHD) in patients with epilepsy stands at around 30-40%, especially the inattentive subtype, while other studies on children diagnosed with ADHD show figures that vary from 6.1% to 30% which present alterations in the electroencephalogram and epilepsy problems. Although clinical practice guidelines advise against treatment with psychostimulants in ADHD that is comorbid with epilepsy, especially when the latter is not considered active, some researchers and practitioners recommend caution as regards beginning this pharmacological therapy, while less research has been conducted on the use of non-psychostimulants.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Ruben Gandia-Beneto"

  • - Ruben Gandia-Beneto's research primarily focuses on attention deficit hyperactivity disorder (ADHD), including its emotional self-regulation aspects and neurophysiological correlates, particularly in relation to P300 evoked potentials in children.
  • - His studies explore the efficacy and management of pharmacological treatments for ADHD, such as methylphenidate and atomoxetine, and emphasize the special considerations needed in patients with comorbid conditions like epilepsy.
  • - Additionally, his work addresses the need for adjustments in therapeutic strategies when children with ADHD show inadequate responses to standard pharmacological treatments, highlighting the complexity of managing this disorder.